Contracts › 75A50122C00047
75A50122C00047: Chimerix Inc: Ar&D for Smallpox Antiviral
Awarded to Emergent Biodefense Operations Lansing Llc by Office of Assistant Secretary for Preparedness and Response.
$213.8Mobligated
$649.8Mpotential value
01 October 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50122C00047 |
|---|---|
| Awardee | Emergent Biodefense Operations Lansing Llc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AJ15 General Science & Technology R&D Svcs; General Science & Technology; R&D Facilities & Maj Equip |
| Place of performance | NC |
| Offers received | 1 |
| Period of performance | 29 August 2022 to 01 October 2028 |
| Potential end | 24 August 2032 |
| Estimated recompete solicitation | ~Q2 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record